Lorna Rothery spoke to a team at Mid Yorkshire Teaching Hospital about the risk factors for and prevention of diabetic foot ...

THE RISING global prevalence of youth-onset Type 2 diabetes (Y-T2D) is a serious public health concern. With an aggressive ...

Over 90% have type 2 diabetes, and the majority of those living with diabetes live in low- or middle-income countries (2). The specific diabetes associated complications-retinopathy, nephropathy and ...

AstraZeneca and Ionis' drug Wainzua (eplontersen) has been recommended for approval in the European Union for treating ...

This form of neuropathy carries a high risk of pain, trophic changes and autonomic dysfunction. There is currently no effective treatment for diabetic neuropathy, and good glycemic control is the ...

Diabetes afflicts more than half a billion people worldwide, and causes nearly seven million deaths a year. In recent decades, the prevalence of this disease characterised by elevated levels of blood ...

The guideline provides updated evidence-based recommendations for nurses and other health providers, and people at risk of or living with diabetic foot ulcers (DFU) on how to prevent, assess and ...

TORONTO, Oct. 17, 2024 /CNW/ - To better support people at risk of or living with a diabetic foot ulcer (DFU), the Registered Nurses' Association of Ontario has released the new edition of its ...

A new treatment combining ReCET and semaglutide eliminated insulin use in 86% of type 2 diabetes patients, improving natural insulin sensitivity. A new treatment combining ReCET and semaglutide could ...

Furthermore, increased accumulation of harmful sugar byproducts, elevated cell waste, damage from oxidative stress, and neuropathy also arise due to chronic diabetes. Taken together, these ...

have collaborated to formulate first-of-its-kind diabetic retinopathy screening guidelines, which will help every physician and diabetologist in India to educate their patients regarding diabetic ...

addressing the critical issue of ongoing patient adherence in the management of type 2 diabetes," she continued. "In addition, the treatment is disease-modifying: it improves the patient's ...